Moxonidine

CHEMBL19236 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

241.7 g/mol

LogP

0.6

Phase

4

This medication is used to treat high blood pressure by acting on receptors in the brain that reduce nerve signals responsible for raising blood pressure. It is taken once or twice daily and is particularly useful for patients who have not responded well to other blood pressure treatments.

Moleküler Ağırlık

241,6800 g/mol

LogP

0,60

TPSA

71,40 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Schizophrenia Obesity Type 2 Diabetes Hypertension Atrial Fibrillation

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1nc(C)nc(Cl)c1NC1=NCCN1

InChI

InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)

Molecular Formula

C9H12ClN5O

HBD / HBA

2 / 4

Döndürülebilir Bağlar

3

Ağır Atomlar

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication is used to treat high blood pressure by acting on receptors in the brain that reduce nerve signals responsible for raising blood pressure. It is taken once or twice daily and is particularly useful for patients who have not responded well to other blood pressure treatments.

Yes, Moxonidine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL19236. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4810. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Moxonidine PillFYI'da

Yapı

Hızlı Veriler

Formül: C9H12ClN5O

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.